Cardiac Marker Testing Devices Market Development by Major Eminent Players, Growth and Forecast 2021 to 2027

Cardiac Marker Testing Devices Market

 Cardiac marker testing detects endogenous substances that are released during blood circulation, primarily when the heart is damaged or stressed, thereby assessing risk and directing appropriate therapy that improves clinical outcomes in high-risk patients. Cardiac markers are used in hospitals to detect a cardiac injury or to assess future risk of cardiovascular disease.

  The troponin cardiac biomarkers segment dominated the global cardiac markers testing market in 2015 and is expected to continue to do so during the forecast period. This is due to the efficiency and accuracy of its test results in diagnosing cardiovascular disorders. The global cardiac markers market is segmented by application, with markers used for myocardial infarction, acute coronary syndrome (ACS), cardiac heart failure, and others. ACS is expected to be the fastest-growing segment, owing to the disorder's increasing prevalence.

  Myocardial infarction is expected to be the second-fastest-growing segment, owing to an increase in sedentary lifestyles, alcohol consumption, smoking, and unhealthy food habits, which lead to obesity. The global cardiac markers testing has been divided into two end-user segments: point-of-care testing and laboratory testing. The laboratory testing segment dominated the global cardiac markers testing market in 2015, but the point-of-care testing segment is expected to gain a disproportionately larger market share during the forecast period.

  The global cardiac markers testing market is divided into creatine kinase (CK), lactate dehydrogenase, aspartate aminotransferase (AST), troponin, myoglobin, C-reactive proteins, natriuretic peptides, and others. Creatine kinase is divided into M and B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment dominated the global cardiac markers testing market in 2015 and is expected to continue to do so during the forecast period. This is due to the efficiency and accuracy of its test results in diagnosing cardiovascular disorders.

  The global cardiac markers market is segmented by application, with markers used for myocardial infarction, acute coronary syndrome (ACS), cardiac heart failure, and others. ACS is expected to be the fastest-growing segment, owing to the disorder's increasing prevalence. Myocardial infarction is expected to be the second-fastest-growing segment, owing to an increase in sedentary lifestyles, alcohol consumption, smoking, and unhealthy food habits, which lead to obesity. The global cardiac testing market has been divided into two end-user segments: point-of-care testing and laboratory testing.

  Siemens Healthineers, Bio-Rad Laboratories, Inc., Avantra Biosciences, Becton, Dickinson and Company, Abbott Laboratories, LSI Medience Corporation, Roche Diagnostics, Randox Laboratories Ltd., Helomics Corporation, and Enzo Biochem are major players in the global cardiac markers testing market.